DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Myriad Genetics, Inc. (MYGN)
« Back to company indexMYGN Chatter Timeline
Stock Ticker for MYGN
Most Active Tweeters for MYGN
| User | Tweets |
|---|---|
| @Rhizome333 | 5 |
| @bulletin_en | 4 |
| @AmericanBanking | 3 |
| @1MinuteStock | 3 |
| @CapitolistPig | 2 |
Recent Tweets for MYGN
 |
@bulletin_en Myriad Genetics $MYGN Holder Tieton Capital Management Has Decreased Its Stake; Church & Dwight $CHD Shareholder Me… https://t.co/qqI85kYZbS May 23rd 2019, 2:05pm |
|
@bulletin_en Mesirow Financial Investment Management Us Value Equity Has Cut Stake in Myriad Genetics $MYGN by $1.79 Million; As… https://t.co/3aO54pSIfO May 23rd 2019, 2:05pm |
 |
@FinZTribune E&G Advisors LP Has Raised Stake in Pinnacle West Cap $PNW; As Myriad Genetics $MYGN Share Price Declined, Tieton C… https://t.co/pudFkzATg8 May 23rd 2019, 9:05am |
 |
@cryptoenlighte1 RT @dakotafinancial: Contrasting Palatin Technologies $PTN and Myriad Genetics $MYGN https://t.co/1SevaeUZAX May 23rd 2019, 4:05am |
 |
@dakotafinancial Contrasting Palatin Technologies $PTN and Myriad Genetics $MYGN https://t.co/1SevaeUZAX May 23rd 2019, 12:05am |
 |
@Tickeron $MYGN Myriad Genetics (MYGN, $25.76) was this quarter's top loser, falling -19% https://t.co/0POzE7KzUs May 22nd 2019, 9:05pm |
 |
@CapitolistPig RT @RodBoydILM: $MYGN misrepresenting? Surely you jest? (/s) Please read @SIRF_Report's two-article series on them: 1. https://t.co/MmGRI2… May 22nd 2019, 4:05pm |
 |
@RodBoydILM $MYGN misrepresenting? Surely you jest? (/s) Please read @SIRF_Report's two-article series on them: 1.… https://t.co/Drgq2Z8WzU May 22nd 2019, 4:05pm |
|
@CapitolistPig @rogersro Also, Their was absolutely no difference on HAMD scores and the $MYGN trial was not powered to look at se… https://t.co/vr8okZgumz May 22nd 2019, 3:05pm |
|
@Tickeron $MYGN Myriad Genetics (MYGN, $25.76) was the month's biggest loser, shedding -20% https://t.co/Xd6PlT5Tm4 May 22nd 2019, 2:05pm |
 |
@macondailynews Myriad Genetics $MYGN Upgraded to Hold by Zacks Investment Research https://t.co/i75EJcpTYa May 21st 2019, 3:05pm |
 |
@Rhizome333 $MYGN loaded up under 25.50 May 20th 2019, 9:05am |
|
@bulletin_en Tieton Capital Management Trimmed Holding in Myriad Genetics $MYGN by $2.32 Million; Restructuring Capital Associat… https://t.co/kLgAQNVKj6 May 19th 2019, 6:05am |
 |
@1MinuteStock Unicorn Bay rating for $MYGN is 1.66 out of 5. https://t.co/nFL9FrJfRr May 18th 2019, 8:05pm |
 |
@DataTrials $MYGN Phase 2 A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fa… https://t.co/NeFU8GOQoX May 18th 2019, 3:05pm |
 |
@dailypoliticaln Myriad Genetics $MYGN Receives Strong-Buy Rating from Needham & Company LLC https://t.co/gaSJLzJ4HR May 17th 2019, 12:05pm |
 |
@TheMarketsDaily Myriad Genetics $MYGN Downgraded by Zacks Investment Research https://t.co/BVkipceoDV May 17th 2019, 10:05am |
 |
@registrarjourn Myriad Genetics $MYGN Downgraded by Zacks Investment Research https://t.co/zUlWwNR0bk May 17th 2019, 10:05am |
 |
@EnterpriseLeade Myriad Genetics $MYGN Downgraded by Zacks Investment Research https://t.co/zFyPfvQ4fF May 17th 2019, 10:05am |
 |
@stocknewstimes Myriad Genetics $MYGN Downgraded by Zacks Investment Research https://t.co/8oG4UskECk May 17th 2019, 10:05am |
 |
@SleekMoneycom Myriad Genetics $MYGN Downgraded by Zacks Investment Research https://t.co/7iit7YDtkl #investing May 17th 2019, 10:05am |
|
@Rhizome333 $MYGN I am a buyer down here, in particular under 26.20... but I doubt these prices last long May 17th 2019, 9:05am |
 |
@bbnsnews Myriad Genetics $MYGN Stock Rating Reaffirmed by Needham & Company LLC https://t.co/6R3v64Ib1K May 16th 2019, 10:05am |
 |
@ProTradersNews $MYGN: Myriad Genetics Reduced 2019 Guidance, but Is It Really So Bad?: https://t.co/xhCCumrfvi May 15th 2019, 8:05am |
 |
@TranscriptDaily Myriad Genetics $MYGN Downgraded by Zacks Investment Research https://t.co/TrCIK18VzD May 15th 2019, 5:05am |
 |
@WatchlistN FY2019 EPS Estimates for Myriad Genetics, Inc. $MYGN Reduced by Svb Leerink https://t.co/799pyAvTVd May 15th 2019, 3:05am |
 |
@ZolmaxNews Recent Analysts’ Ratings Updates for Myriad Genetics $MYGN https://t.co/0B4hR9tDJC May 14th 2019, 5:05pm |
 |
@AmericanBanking Recent Analysts’ Ratings Updates for Myriad Genetics $MYGN https://t.co/H8HwmKF7XJ #stocks May 14th 2019, 5:05pm |
|
@Rhizome333 $MYGN stopped out, looking to get back in low 26s May 14th 2019, 3:05pm |
|
@AmericanBanking Needham & Company LLC Reiterates Strong-Buy Rating for Myriad Genetics $MYGN https://t.co/oNUKV0JFPC #stocks May 14th 2019, 8:05am |
 |
@TickerReport Myriad Genetics $MYGN Given Strong-Buy Rating at Needham & Company LLC https://t.co/5a6NkINBsF May 14th 2019, 8:05am |
|
@Rhizome333 $MYGN might be worth a buy on the dip today May 13th 2019, 8:05am |
|
@AmericanBanking Svb Leerink Comments on Myriad Genetics, Inc.’s FY2019 Earnings $MYGN https://t.co/siz9KBUumL #stocks May 13th 2019, 3:05am |
 |
@ConsumerFeed Svb Leerink Comments on Myriad Genetics, Inc.’s FY2019 Earnings $MYGN https://t.co/bMmGXk0ngw May 13th 2019, 3:05am |
|
@bulletin_en Tieton Capital Management Has Lowered Its Myriad Genetics $MYGN Position by $2.32 Million; Share Value Declined; As… https://t.co/Nj5Nk0mBOT May 12th 2019, 12:05pm |
|
@1MinuteStock Do you know that #Book Value for $MYGN is $14.74 https://t.co/yyU77g9193 May 12th 2019, 9:05am |
 |
@SwingTradeBot Recent $MYGN technical alerts: Calm After Storm plus 19 more alerts... https://t.co/1ayvR7H0Cj May 12th 2019, 9:05am |
|
@1MinuteStock Wondering about risks of $MYGN? The 21-day volatility is 22.91% https://t.co/CJdCMrKQTJ May 12th 2019, 8:05am |
|
@bbnsnews Myriad Genetics $MYGN Downgraded to Sell at ValuEngine https://t.co/soHCeEYtgb May 12th 2019, 8:05am |
 |
@dispatchtribune Myriad Genetics $MYGN Lowered to Sell at ValuEngine https://t.co/9iaSLibGYe May 11th 2019, 12:05pm |
|
@Rhizome333 $MYGN $30 next week May 10th 2019, 3:05pm |
 |
@WeekHerald Myriad Genetics $MYGN Stock Rating Lowered by ValuEngine https://t.co/RY8uA0f1tu May 10th 2019, 3:05am |
|
@TranscriptDaily Myriad Genetics $MYGN Sets New 1-Year Low Following Weak Earnings https://t.co/Yml6fyU2nl May 10th 2019, 1:05am |
|
@TickerReport Myriad Genetics, Inc. $MYGN Receives Average Rating of “Hold” from Analysts https://t.co/RE4EY5K3qy May 10th 2019, 12:05am |
 |
@intercooleronli Myriad Genetics, Inc. $MYGN Stake Increased by Raymond James & Associates https://t.co/eWPg0hH3wL #investingnews May 9th 2019, 9:05pm |
 |
@ledgerzette Myriad Genetics, Inc. $MYGN Stake Increased by Raymond James & Associates https://t.co/qG4YTwCHLY #stocks May 9th 2019, 9:05pm |
|
@dispatchtribune Myriad Genetics $MYGN Issues Q4 Earnings Guidance https://t.co/wPsNfCOolp May 9th 2019, 4:05pm |
 |
@OlympiaReport Myriad Genetics $MYGN Issues Quarterly Earnings Results, Misses Estimates By $0.04 EPS https://t.co/dPf0imvm15 May 9th 2019, 1:05pm |
|
@Rhizome333 $MYGN back to $30 sooner than later May 9th 2019, 11:05am |
|
@SwingTradeBot $MYGN technical alerts: Expansion Pivot Sell Setup, MACD Bearish Signal Line Cross, MACD Bearish ... https://t.co/1ayvR7H0Cj May 9th 2019, 8:05am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.